A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy

Gut

Volumn 63, Issue 7, 2014, Pages 1112-1119

  Kaminski, Michal F ^a,b   Polkowski, Marcin ^a,b   Kraszewska, Ewa ^b   Rupinski, Maciej ^a,b   Butruk, Eugeniusz ^c   Regula, Jaroslaw ^a,b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c Polish Foundation of Gastroenterology   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CALIBRATION; CANCER RISK; CANCER SCREENING; CAUCASIAN; COLONOSCOPY; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDITY;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLAND; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84902265451     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-304965     Document Type: Article

References (49)

1. Littlejohn C, Hilton S, Macfarlane GJ, et al. Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg 2012;99:1488-500.
2. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; (1): CD001216.
3. von Karsa L, Patnick J, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013;45:51-9.
4. Logan RF, Patnick J, Nickerson C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61:1439-46.
5. Pox CP, Altenhofen L, Brenner H, et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012;142:1460-7 e2.
6. Khalid-de Bakker C, Jonkers D, Smits K, et al. Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy 2011;43:1059-86.
7. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22. (Pubitemid 27419204)
8. Klabunde CN, Vernon SW, Nadel MR, et al. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 2005;43:939-44. (Pubitemid 41323144)
9. Lieberman DA, Weiss DG, Bond JH. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-68. (Pubitemid 30489212)
10. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72. (Pubitemid 44664644)
11. Betes M, Munoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003;98:2648-54. (Pubitemid 38020103)
12. Nguyen SP, Bent S, Chen YH, et al. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009;7:676-81 e1-3.
13. Taylor DP, Burt RW, Williams MS, et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 2010;138:877-85.
14. Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008;134:388-95.
15. Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003;290:2959-67. (Pubitemid 37505528)
16. Terry MB, Neugut AI, Bostick RM, et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002;11:622-9. (Pubitemid 34760820)
17. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-87. (Pubitemid 41672234)
18. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009;101:256-66.
19. Larsson SC, Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 2006;119:2657-64. (Pubitemid 44691322)
20. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
21. Neter J, Kutner MH, Nachtsheim CJ, et al. Applied linear statistical models. 4th edn. Chicago: Irwin, 1996.
22. Hosmer DWJ, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
23. Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol 2009;27:694-8.
24. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
25. Latreille MW, Anderson JC. Colonoscopy screening for detection of advanced neoplasia. N Engl J Med 2007;356:632; author reply 33-4. (Pubitemid 46220824)
26. Foster P, Anderson CM. Reaching targets in the national cervical screening programme: are current practices unethical? J Med Ethics 1998;24:151-7. (Pubitemid 28274479)
27. van Vugt HA, Roobol MJ, Venderbos LD, et al. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator. Eur J Cancer 2010;46:669-77.
28. Gail MH, Pfeiffer RM. On criteria for evaluating models of absolute risk. Biostatistics 2005;6:227-39. (Pubitemid 41240355)
29. Lin OS, Kozarek RA, Schembre DB, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology 2006;131:1011-19. (Pubitemid 44515105)
30. Pepe MS, Janes H, Longton G, et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882-90. (Pubitemid 38657490)
31. Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011;60:1236-41.
32. Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol 2012;175:584-93.
33. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol 2013. Published Online First: 8 Sept 2013. pii: S1542-3565 (13) 01297-4. doi: 10.1016/j.cgh.2013.08.042
34. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105:2017-25.
35. Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013;49:3049-54.
36. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010;105:682-90.
37. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162-9.
38. Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut 2014;63:466-71.
39. Omata F, Shintani A, Isozaki M, et al. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol 2011;23:1036-41.
40. Polakowska M, Piotrowski W. Incidence of diabetes in the Polish population: results of the Multicenter Polish Population Health Status Study-WOBASZ. Pol Arch Med Wewn 2011;121:156-63.
41. Wiszniewski M, Kaminski MF, Kraszewska E, et al. Distribution of life style factors and family history of colorectal cancer and the risk of advanced neoplasia in opportunistic versus organized screening. Gastroenterology 2011;140:S412.
42. Wei EK, Colditz GA, Giovannucci EL, et al. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol 2009;170:863-72.
43. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. Am J Clin Oncol 2009;27:686-93.
44. Cuzick J, Cafferty FH, Edwards R, et al. Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen 2007;14:178-85. (Pubitemid 350223781)
45. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81. (Pubitemid 24015040)
46. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
47. Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol 2013;37:278-83.
48. Kolligs FT, Crispin A, Munte A, et al. Risk of advanced colorectal neoplasia according to age and gender. PloS ONE 2011;6:e20076.
49. Lansdorp-Vogelaar I, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Introduction. Endoscopy 2012;44(Suppl 3):SE15-30.